Ryan & Maniskas, LLP Announces Investigation of Osteotech, Inc.
18 Agosto 2010 - 12:15AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/oste) is
investigating potential claims against the board of directors of
Osteotech, Inc. ("Osteotech" or the "Company") (NASDAQ: OSTE)
concerning possible breaches of fiduciary duty and other violations
of law related to the Company’s entry into an agreement to be
acquired by Medtronic, Inc. in a transaction with a value of
approximately $123 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to approval of the transaction
by Company’s board of directors; in particular, whether the Company
undertook a fair process to obtain fair consideration for all
shareholders of Osteotech. For more information regarding our
investigation, please contact Ryan & Maniskas, LLP (Richard A.
Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/oste.
Under the terms of the proposed transactions, Company
shareholders will receive $6.50 in cash for each share of Osteotech
common stock they hold.
If you own shares of Osteotech and would like to learn more
about these claims or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/oste. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan and Maniskas, LLP is devoted to protecting the interests
of individual and institutional investors in shareholder actions in
state and federal courts nationwide.
Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Osteotech Com (MM) (NASDAQ): 0 articoli recenti
Più Ryan & Maniskas, LLP Articoli Notizie